JP2008531696A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531696A5
JP2008531696A5 JP2007558097A JP2007558097A JP2008531696A5 JP 2008531696 A5 JP2008531696 A5 JP 2008531696A5 JP 2007558097 A JP2007558097 A JP 2007558097A JP 2007558097 A JP2007558097 A JP 2007558097A JP 2008531696 A5 JP2008531696 A5 JP 2008531696A5
Authority
JP
Japan
Prior art keywords
blood
blood stem
stem cells
tvemf
cell composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007558097A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531696A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/006829 external-priority patent/WO2006093860A2/en
Publication of JP2008531696A publication Critical patent/JP2008531696A/ja
Publication of JP2008531696A5 publication Critical patent/JP2008531696A5/ja
Pending legal-status Critical Current

Links

JP2007558097A 2005-02-28 2006-02-27 心臓の組織を治療するための方法および組成 Pending JP2008531696A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65728705P 2005-02-28 2005-02-28
PCT/US2006/006829 WO2006093860A2 (en) 2005-02-28 2006-02-27 Method and composition for repairing heart tissue

Publications (2)

Publication Number Publication Date
JP2008531696A JP2008531696A (ja) 2008-08-14
JP2008531696A5 true JP2008531696A5 (cg-RX-API-DMAC7.html) 2009-04-16

Family

ID=36941686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007558097A Pending JP2008531696A (ja) 2005-02-28 2006-02-27 心臓の組織を治療するための方法および組成

Country Status (11)

Country Link
US (1) US20060193836A1 (cg-RX-API-DMAC7.html)
EP (1) EP1853301A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008531696A (cg-RX-API-DMAC7.html)
KR (1) KR20070112205A (cg-RX-API-DMAC7.html)
CN (1) CN101166541A (cg-RX-API-DMAC7.html)
BR (1) BRPI0608277A2 (cg-RX-API-DMAC7.html)
CA (1) CA2599332A1 (cg-RX-API-DMAC7.html)
EA (1) EA200701599A1 (cg-RX-API-DMAC7.html)
IL (1) IL185557A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007010451A (cg-RX-API-DMAC7.html)
WO (1) WO2006093860A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060193839A1 (en) * 2005-02-28 2006-08-31 Donnie Rudd Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
MY147516A (en) 2005-11-07 2012-12-31 Amorcyte Inc Compositions and method of vascular injury repair cross-reference to related applications
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20090081752A1 (en) * 2007-09-24 2009-03-26 Dennis Robert G Bioreactor, kit and method of using same
US8993231B2 (en) * 2008-03-18 2015-03-31 Marshall University Research Corporation Methods for stem cell production and therapy
JP5705127B2 (ja) * 2008-12-03 2015-04-22 アモーサイト インコーポレイテッド 梗塞領域灌流改善組成物および血管損傷修復の方法
SG11201603166UA (en) 2013-10-24 2016-05-30 Ospedale San Raffaele Srl Method
US9410143B1 (en) 2014-06-10 2016-08-09 Endonovo Therapeutics, Inc. Biological molecules produced by electromagnetically stimulating living mammalian cells
CN111313782B (zh) * 2020-01-20 2022-03-01 江苏新安电器股份有限公司 基于免疫算法的感应电机无源性控制方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5153132A (en) * 1988-06-30 1992-10-06 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Three-dimensional co-culture process
US5026650A (en) * 1988-06-30 1991-06-25 The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration Horizontally rotated cell culture system with a coaxial tubular oxygenator
US4988623A (en) * 1988-06-30 1991-01-29 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Rotating bio-reactor cell culture apparatus
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US20020159984A1 (en) * 1999-11-12 2002-10-31 Quality Biological, Inc. Cultivation of cells for long term engraftment
US6485963B1 (en) * 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
AU2002220712A1 (en) * 2000-11-29 2002-06-11 William Rader Stem cells, method for expansion in vitro and use thereof
US20040076620A1 (en) * 2002-09-03 2004-04-22 Donnie Rudd Method of repairing primate mammalian tissue
US20060051860A1 (en) * 2002-11-15 2006-03-09 Kyushu Tlo Company, Limited Method of organ regeneration
US20050084962A1 (en) * 2003-08-20 2005-04-21 Bruce Simon Methods of treatment using electromagnetic field stimulated stem cells
US20080057042A1 (en) * 2005-01-27 2008-03-06 Donnie Rudd Method of providing readily available cellular material derived from cord blood, and a composition thereof
US20080050348A1 (en) * 2006-02-27 2008-02-28 Donnie Rudd Method and composition for repairing heart tissue
US20080075700A1 (en) * 2006-02-27 2008-03-27 Wolf David A Method and composition for treating diabetes

Similar Documents

Publication Publication Date Title
US5199942A (en) Method for improving autologous transplantation
Cheng et al. Mesenchymal stem cell administration in patients with chronic obstructive pulmonary disease: state of the science
Rosca et al. Emerging role of stem cells-derived exosomes as valuable tools for cardiovascular therapy
ES2939635T3 (es) Métodos y composiciones para el trasplante de células madre
Shim et al. G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?
Chen et al. Timing of transplantation of autologous bone marrow derived mesenchymal stem cells for treating myocardial infarction
AU2016364934A1 (en) Uses of expanded populations of hematopoietic stem/progenitor cells
US20060188984A1 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
JP2008531696A5 (cg-RX-API-DMAC7.html)
ES2486300T3 (es) Composiciones y métodos de reparación de lesiones vasculares
WO2006093857A2 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
CN105814072A (zh) 一种五环三萜结构修饰化合物及其制备方法和应用
RU2006106228A (ru) Фармацевтическая композиция, используемая для мобилизации стволовых клеток
WO2004005494A1 (es) Medio de cultivo de células madre-progenitoras autólogas humanas y sus aplicaciones
CN109511650B (zh) 一种可以扩大供肝来源的常温机械灌注液
Chen et al. Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
Tianhang et al. Autologous transplantation of endothelial progenitor cells to prevent multiple organ dysfunction syndromes in pig
KR20070112205A (ko) 심장 조직 재생용 조성물 및 방법
CA2593161A1 (en) Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
WO2021200299A1 (ja) 細胞老化抑制剤、生体組織修復促進剤、遺伝子発現調節剤及び製造方法
JP2009517078A5 (cg-RX-API-DMAC7.html)
JPH05317041A (ja) 動物細胞増殖促進剤及び無血清培地
JP2008531695A5 (cg-RX-API-DMAC7.html)
WO2009025827A1 (en) Method and composition for repairing epithelial and other cells and tissue
JP2012533519A5 (cg-RX-API-DMAC7.html)